Yeztugo/Injectable Lenacapavir Clinician Training

Injectable lenacapavir (YeztugoⓇ) is a new twice-yearly long-acting injectable form of HIV PrEP that is >99% effective for preventing sexual transmissions of HIV in all genders. This training, led by a Medical Scientist and Nurse Educator team from Gilead Sciences (YeztugoⓇ manufacturer), will provide an overview of injectable lenacapavir prescribing and administration, alongside a detailed training on proper administration techniques for staff who will be administering lenacapavir injections. 

This training is primarily for clinical staff who will be administering LEN PrEP injections (RN, MA, MD, NP, PA, etc), and will also be open for staff who are interested in becoming more knowledgeable about LEN PrEP injections (space permitting)

Please note registration preference will be given to clinical staff who will be administering injectable lenacapavir at their clinical sites, but will also be open to additional staff who are interested in becoming more knowledgeable about lenacapavir PrEP, space permitting.

Register to join the training here.